United States interventional cardiology devices market is expected to grow at a significant rate during the forecast period. Increasing prevalence of coronary artery diseases is driving the demand for interventional cardiology devices market. Surge in adoption of unhealthy lifestyle such as consumption of junk food and sugary food items and beverages is expected to give rise to a number of health-related issues. Prevalence of sedentary lifestyle which leaves less time for physical activities is also a major reason for generation of health disorders.
Rise in occurrence of diabetes and hypertension which are the most common diseases in United States raise the risk of getting affected of coronary heart disease. Strong economic position and well-developed healthcare infrastructure is aiding to the market growth of interventional cardiology devices. Rise in health awareness among the people is supporting the adoption of advanced medical treatment devices such as interventional cardiology devices which is accelerating the market growth. Increasing expenditure capacity among the patients and the high demand for quality treatment is paving the way for the interventional cardiology devices market growth.
United States interventional cardiology devices market is segmented into
The major players operating in the United States interventional cardiology devices market are Medtronic USA, Inc., Boston Scientific Corporation, Abbott Laboratories, Inc., Biotronik, Inc., Edwards LifeSciences Corporation, Cardinal Health, Inc., B. Braun Medical Inc., Terumo Americas Holding Inc., Cordis Corporation, Cook Medical Inc., among others. Major companies are developing advanced technologies and launching new services to stay competitive in the market. Other competitive strategies include mergers & acquisitions and new service developments.
Objective of the Study
- To analyze the historical growth of the market size of United States interventional cardiology devices market from 2017 to 2020.
- To estimate and forecast the market size of United States interventional cardiology devices market from 2021 to 2027 and growth rate until 2027.
- To classify and forecast United States interventional cardiology devices market based on type, end user, regional distribution, and company.
- To identify dominant region or segment in the United States interventional cardiology devices.
- To identify drivers and challenges for United States interventional cardiology devices market.
- To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in United States interventional cardiology devices market.
- To identify and analyze the profile of leading players operating in United States interventional cardiology devices market.
- To identify key sustainable strategies adopted by market players in United States interventional cardiology devices market.
Click here to download the sample
Market insights research performed both primary as well as exhaustive secondary research for this study. Initially, Market insights research sourced a list of manufacturers across the globe. Subsequently, Market insights research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, Market insights research could include the manufacturers who could not be identified due to the limitations of secondary research. Market insights research analyzed the manufacturers, distribution channels and presence of all major players across the globe.
Market insights research calculated the market size of
Key Target Audience
- Interventional cardiology devices manufacturing companies
- Market research and consulting firms
- Government bodies such as regulating authorities and policy makers
- Organizations, forums, and alliances related to interventional cardiology devices market.
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.
| Attribute | Details |
| Base Year | 2021 |
| Historical Years | 2017 – 2020 |
| Estimated Year | 2022E |
| Forecast Period | 2023F – 2027F |
| Quantitative Units | Revenue in USD Million and CAGR for 2017-2021 and 2022E-2027F |
| Report Coverage | Revenue forecast, company share, competitive landscape, growth factors, and trends |
| Segments Covered | |
| Region Scope | South-Region, West-Region, Mid-West Region & Northeast-Region |
| Key Companies Profiled | Medtronic USA, Inc., Boston Scientific Corporation, Abbott Laboratories, Inc., Biotronik, Inc., Edwards LifeSciences Corporation, Cardinal Health, Inc., B. Braun Medical Inc., Terumo Americas Holding Inc., Cordis Corporation, Cook Medical Inc. |
| Customization Scope | 10% free report customization with purchase. Addition or alteration to regional & segment scope. |
| Pricing and Purchase Options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
